Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = The Breast

Refine Results

Resource Type

Availability

Creation Date

Show more

Language

Search results

  • RSS Feed
(1 - 20 of 27)

Pages

Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction
Breast cancer, breast cancer-directed radiation therapy and risk of hypothyroidism: a systematic review and meta-analysis
Response to: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?
Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Information needs on breast cancer genetic and non-genetic risk factors in relatives of women with a BRCA1/2 or PALB2 pathogenic variant
Who are the women who enrolled in the POSITIVE trial
Decisional conflict in breast cancer patients considering immediate breast reconstruction
The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer
Risk communication in a patient decision aid for radiotherapy in breast cancer
The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: a systematic review
Health-related quality of life of breast cancer patients after accelerated partial breast irradiation using intraoperative or external beam radiotherapy technique
Risk factors for metachronous contralateral breast cancer: A systematic review and meta-analysis
Psychological factors associated with the intention to choose for risk-reducing mastectomy in family cancer clinic attendees
Don't forget the dentist: Dental care use and needs of women with breast cancer
Importance of patient reported outcome measures versus clinical outcomes for breast cancer patients evaluation on quality of care
Serum vit D levels and response to molecular subtypes in breast cancer Reply
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)
Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients
Feasibility of tailored follow-up for patients with early breast cancer
Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group

Pages